Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
21.48
+0.36 (1.70%)
Nov 16, 2026, 3:20 PM EST - Market open
Assembly Biosciences Revenue
Assembly Biosciences had revenue of $2.96M in the quarter ending September 30, 2026, a decrease of -72.60%. This brings the company's total for the last twelve months to $67.01M, up 80.18% year-over-year. In the year 2025, Assembly Biosciences had annual revenue of $72.30M with 153.52% growth. That makes Assembly Biosciences the 25,809th largest company in the world by revenue and 3,567th in the United States.
Revenue (ttm)
$67.01M
Revenue Growth
+80.18%
P/S Ratio
6.64
Revenue / Employee
$917,973
Employees
73
Market Cap
439.85M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.30M | 43.78M | 153.52% |
| Dec 31, 2024 | 28.52M | 21.36M | 298.16% |
| Dec 31, 2023 | 7.16M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 6.25M | -72.85M | -92.09% |
| Dec 31, 2020 | 79.11M | 63.14M | 395.55% |
| Dec 31, 2019 | 15.96M | 1.16M | 7.83% |
| Dec 31, 2018 | 14.80M | 5.79M | 64.14% |
| Dec 31, 2017 | 9.02M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MiMedx Group | 303.73M |
| Arvinas | 275.30M |
| Fennec Pharmaceuticals | 66.37M |
| CytomX Therapeutics | 14.03M |
| Oculis Holding AG | 1.12M |
| Shattuck Labs | 1.00M |
| Avalo Therapeutics | 59.00K |
ASMB News
- 8 hours ago - Assembly Biosciences Transcript: UBS Global Biopharma Conference 2026 - Transcripts
- 3 days ago - Assembly Biosciences reports Q3 EPS (93c), consensus (49c) - TheFly
- 3 days ago - Assembly Biosciences Reports Third Quarter 2026 Financial Results and Recent Updates - GlobeNewsWire
- 3 days ago - Assembly Biosciences Earnings release: Q3 2026 - Filings
- 3 days ago - Assembly Biosciences Quarterly report: Q3 2026 - Filings
- 6 days ago - Assembly Biosciences Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 13 days ago - Assembly Biosciences price target lowered to $48 from $52 at UBS - TheFly
- 13 days ago - Assembly Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire